Publiziert in: Marktpuls, Unternehmen
Frei

Roche Investor Update: Save the date: Roche Analyst Event at ASCO 2017 Dienstag, 11. April 2017 - 10:28

Investor Update

E2498B80-83EC-7344-8D76-E8C28EC1C69F.jpg
 

Save the date: Roche Analyst Event at ASCO 2017 - Monday, 5 June 2017

divider.png

We are pleased to invite you to an analyst briefing to discuss data presented on the Roche Group’s oncology products and pipeline at the American Society of Clinical Oncology Annual Meeting (ASCO) in Chicago (2 – 6 June 2017).

Venue
Marriott Downtown Chicago
540 North Michigan Avenue
60611 Chicago
map

Date/Time
Monday, 5 June 2017 @ 5:15pm Central Daylight Time CDT (Chicago)
The briefing will be followed by a buffet reception.

An invitation with the detailed programme and registration form will soon follow.

Best regards,

Karl Mahler
Head of Investor Relations

Sabine Borngräber
Investor Relations Officer

 
 

Roche Investor Relations

Dr. Karl Mahler 
Phone: +41 61 68-78503 
e-mail: karl.mahler@roche.com                 

Dr. Bruno Eschli 
Phone: +41 61 68-75284 
e-mail: bruno.eschli@roche.com 

Dr. Birgit Masjost 
Phone: +41 61 68-84814 
e-mail: birgit.masjost@roche.com

Dr. Sabine Borngräber 
Phone: +41 61 68-88027 
e-mail: sabine.borngraeber@roche.com 

Dr. Tamer Farhan 
Phone: +41 61 68-82552 
e-mail: tamer.farhan@roche.com 

Dr. Susann Weissmüller 
Phone: +41 61-68-75619 
e-mail: susann.weissmueller@roche.com


Investor Relations North America

Neera Dahiya Ravindran, MD 
Phone: +1 650 491 5281 
e-mail: ravindran.neera@gene.com           

Loren Kalm 
Phone: +1 650 225 3217 
e-mail: kalm.loren@gene.com